The 3 Most Important Numbers on an Earnings Report

A quick look at Canopy Growth Corp’s (TSX:WEED(NYSE:CGC) recent quarterly results makes it easy to see why the stock has struggled over the past year.

| More on:
Piggy bank next to a financial report

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Cannabis stocks have been under the spotlight this year as poor earnings numbers have weighed heavily on the industry.

Canopy Growth Corp (TSX:WEED(NYSE:CGC) is a great example of a company that’s seen a big correction in recent months and could be in danger of falling further if it continues to underperform.

Below, I’ll look at what are three of the most important numbers investors should be looking at on earnings report and how they’ve affected Canopy Growth:

Sales

One of the most important numbers for any stock is how strong its sales have been. However, more than just overall sales, the company’s forecast for how it will do in future periods is critical.

One of the problems for Canopy Growth is that while the company has done a great job of growing its sales, it has been a bit too aggressive in making its projections.

Prior to legalization, then-CEO Bruce Linton once said he expected to see hundreds of retail stores in the company’s home province of Ontario being run by Canopy Growth, which just isn’t a possibility under the province’s current rules for pot shops. The retail model has struggled on many fronts and it has impacted many pot stocks in the industry.

But it’s not as simple as just sales growth as investors will be looking at comparables, and that means looking at organic sales growth.

Simply acquiring companies and being able to add their revenue into the mix isn’t going to be enough, investors are going to want to see that the business that was in place a year ago is doing better in the current year.

That’s why sales are evaluated against analyst expectations since they will take into account all of those factors.

Operating income

Many investors focus on net income or adjusted earnings figures, but the one that I find most reliable is a company’s operating income. Without the noise of net income or the subjectivity of adjusted earnings, operating income tells investors how profitable a company is from its day-to-day operations.

In Canopy Growth’s case, it would actually paint a bit of a better picture for the company, as over the past four quarters, its net loss of $1.9 billion has far outweighed its operating loss of $635k during that time.

However, it does give investors a glance at just how much of an impact taxes and non-operating items have been affecting the company’s bottom line.

Free cash flow

For me, the most important figure on a company’s earnings report is its free cash flow. Accounting income can often be misleading and fail to tell the whole story.

The amount of cash that the company is generating after its day-to-day operations and capital expenditures shows what kind of position it’s in and whether it can grow in the status quo or if it’ll need to raise funds.

Canopy Growth’s negative free cash of $1.4 billion over the trailing 12 months certainly raises some concerns. And while it may be able to benefit from having a big investor backing the company, it’s a sign that the company still has a long way to go in becoming a sustainable business.

Bottom line

There can be a lot of noise on a company’s earnings report, and by focusing on the three items above, investors can have a more accurate depiction of just how well a company did.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »